Xyclon 1 mg (Tablet)
Unit Price: ৳ 8.00 (5 x 10: ৳ 400.00)
Strip Price: ৳ 80.00
Medicine Details
Category | Details |
---|---|
Generic | Clonazepam |
Company | Ziska pharmaceuticals ltd |
Also available as |
Indications
- Treatment of panic disorder
- Treatment of Lennox-Gastaut Syndrome
- Treatment of akinetic and myoclonic seizures
- Adjunct in the treatment of absence seizures
Pharmacology
- Anticonvulsive effects
- Sedative effects
- Muscle relaxing effects
- Anxiolytic effects
- Enhancement of GABAergic neurotransmission
- Effect on serotonin
- Suppression of paroxysmal activity
Dosage & Administration
- Initial dose for adults with seizure disorders
- Initial dose for adults with panic disorder
- Initial dose for pediatric patients
- Dosing increments for seizure control
- Maintenance dosage for seizure control
- Maximum recommended daily dose
- Dosage for injection in infants, children, and adults
Interaction
- No alteration of phenytoin pharmacokinetics
- No alteration of carbamazepine pharmacokinetics
- No alteration of phenobarbital pharmacokinetics
- Impact on metabolism of other drugs not investigated
Contraindications
- Hypersensitivity to benzodiazepines
- Clinical or biochemical evidence of significant liver disease
- Open angle glaucoma (with appropriate therapy)
Side Effects
- CNS depression
- Drowsiness
- Ataxia
- Behavior problems
- Abnormal eye movements
- Aphonia
- Coma
- Tremor
- Vertigo
- Confusion
- Depression
- Amnesia
- Hallucinations
- Increased libido
- Insomnia
- Psychosis
- Palpitations
Pregnancy & Lactation
- Teratogenic potential
- Administration during pregnancy if benefits outweigh risks
- Potential effects on the newborn
- Presence in maternal milk
- Discontinuation of breastfeeding
Precautions & Warnings
- Increased incidence of generalized tonic-clonic seizures
- Concomitant use with valproic acid
- Increased pharmacologic effects in elderly patients
- Unchanged pharmacokinetics in renal impairment
- Altered plasma protein binding in cirrhotic patients
Use in Special Populations
- Increased salivation and bronchial secretion in infants and small children
- Greater pharmacologic effects in geriatric patients
- No dose adjustment in renal impairment
- Effect on plasma protein binding in cirrhotic patients
Overdose Effects
- Common symptoms
- Potential life-threatening effects
- Supportive measures
- Activated charcoal use
- Consideration of flumazenil use
- Recommendations for use of flumazenil
Therapeutic Class
- Adjunct anti-epileptic drugs
- Benzodiazepine hypnotics
Reconstitution
- Preparation for slow intravenous injection
- Preparation for intravenous infusion
- Stability of diluting media
- Use of infusion bags
- Use of intramuscular injection
Storage Conditions
- Dry place
- Away from light and heat
- Out of the reach of children
Chemical Structure
- Molecular Formula
- C15H10ClN3O3
- Chemical Structure Image
Common Questions about Xyclon 1 mg Tablet
- Use as a sleeping pill
- Length of treatment
- Withdrawal symptoms upon discontinuation
- Early symptoms of suicidal thoughts and actions
- Potential for weight gain
- Effect on memory
- Harmful effects of overdose
- Potential interactions with other medications
- Quick Tips